| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -1.1e-05 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |